English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/41592
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements

AuthorsPuig-Kröger, Amaya ; Sánchez-Elsner, Tilman; Ruiz, Natividad; Andreu, Enrique J.; Prosper, Felipe; Jensen, Uffe B; Gil, Juana; Erickson, Paul; Drabkin, Harry; Groner, Yoram; Corbí, Angel L.
Keywordsmyeloid cells
leukemia cells
Issue Date1-Nov-2003
PublisherAmerican Society of Hematology
CitationBlood 102:3252-3261 (2003)
AbstractThe CD11a/CD18 (leukocyte function-associated antigen 1 [LFA-1]) integrin mediates critical leukocyte adhesive interactions during immune and inflammatory responses. The CD11a promoter directs CD11a/CD18 integrin expression, and its activity in lymphoid cells depends on a functional RUNX1/AML-1–binding site (AML-110) within the MS7 sequence. We now report that MS7 contains a C/EBP-binding site (C/EBP-100), which overlaps with AML-110 and is bound by C/EBP factors in myeloid cells. C/EBP and RUNX/AML factors compete for binding to their respective cognate elements and bind to the CD11a promoter MS7 sequence in a cell lineage- and differentiation-dependent manner. In myeloid cells MS7 is primarily recognized by C/EBP factors in proliferating cells whereas RUNX/AML factors (especially RUNX3/AML-2) bind to MS7 in differentiated cells. RUNX3/AML-2 binding to the CD11a promoter correlates with increased RUNX3/AML-2 protein levels and enhanced CD11a/CD18 cell surface expression. The relevance of the AML-110 element is underscored by the ability of AML-1/ETO to inhibit CD11a promoter activity, thus explaining the low CD11a/CD18 expression in t(8;21)–containing myeloid leukemia cells. Therefore, the expression of the CD11a/CD18 integrin in myeloid cells is determined through the differential occupancy of the CD11a proximal promoter by transcription factors implicated in the pathogenesis of myeloid leukemia.
Description10 Figures. The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked ‘‘advertisement’’ in accordance with 18 U.S.C. section 1734.
Publisher version (URL)http://bloodjournal.hematologylibrary.org/content/102/9/3252.abstract
URIhttp://hdl.handle.net/10261/41592
DOI10.1182/blood-2003-02-0618
ISSN0006-4971
E-ISSN1528-0020
Appears in Collections:(CIB) Artículos
Files in This Item:
There are no files associated with this item.
Show full item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.